✦ LIBER ✦
6617 POSTER Does the use of erlotinib for the treatment of relapsed stage IIIB/IV NSCLC patients improve quality-adjusted survival compared with docetaxel?
✍ Scribed by Lewis, G.; Creeden, J.; Gyldmark, M.
- Book ID
- 121983174
- Publisher
- Elsevier Science
- Year
- 2007
- Tongue
- English
- Weight
- 56 KB
- Volume
- 5
- Category
- Article
- ISSN
- 1359-6349
No coin nor oath required. For personal study only.